Growth rate of corpus callosum in very premature infants

American Journal of Neuroradiology

Volumn 26, Issue 10, 2005, Pages 2685-2690

  Anderson, Nigel G ^a   Laurent, Isabelle ^b   Cook, Nick ^a   Woodward, Lianne ^c   Inder, Terrie E ^a,d,e  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b Grenoble Medical University   (France)

^c UNIVERSITY OF CANTERBURY   (New Zealand)

^d MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^e FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; ELECTROENCEPHALOGRAPHY; FEMALE; GESTATIONAL AGE; GROWTH RATE; HOSPITAL ADMISSION; HUMAN; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; NEWBORN INTENSIVE CARE; PREMATURITY; PROGNOSIS; RATING SCALE; COMPARATIVE STUDY; DOPPLER ECHOGRAPHY; ECHOGRAPHY; GROWTH, DEVELOPMENT AND AGING; METHODOLOGY; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; RADIOGRAPHY; REPRODUCIBILITY; SMALL FOR DATE INFANT; STATISTICAL MODEL; VERY LOW BIRTH WEIGHT;

CORPUS CALLOSUM; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, SMALL FOR GESTATIONAL AGE; INFANT, VERY LOW BIRTH WEIGHT; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; PSYCHOMOTOR PERFORMANCE; REPRODUCIBILITY OF RESULTS; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 33644846034     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Juul S. Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischaemic brain damage. Acta Paediatr Suppl 2002;91:36-42
2. Crowther CA, Miller JE, Doyle LW, Haslam RR. Australasian Collaborative Trial of Magnesium Sulphate (ACTOMgSO4) Collaborative Group: effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 2003;290:2669-2676
3. Volpe JJ. Cerebral white matter injury of the premature infant-more common than you think. Pediatrics 2003;112:176-180
4. Shankaran S, Laptook A. Challenge of conducting trials of neuro-protection in the asphyxiated term infant. Semin Perinatol 2003;27:320-332
5. Peterson BS, Anderson AW. Ehrenkranz R, et al. Regional brain volumes and their later neurodevelopmental correlates in term and preterm infants. Pediatrics 2003;111:939-948
6. Pinto-Martin JA, Whitaker AH, Feldman JF, et al. Relation of cranial ultrasound abnormalities in low-birthweight infants to motor or cognitive performance at ages 2, 6, and 9 years. Dev Med Child Neurol 1999;41:826-833
7. Stewart AL, Rifkin L, Amess PN, et al. Brain structure and BCU-rocognitive and behavioural function in adolescents who were born very preterm. Lancet 1999;353:1653-1657
8. Miller SP, Scozzio, Goldstein RB, et al. Comparing the diagnosis of white matter injury in premature newborns with serial MR imaging and transfontanel ultrasonography findings. AJNR Am J Neuroradiol 2003;24:1661-1669
9. Malinger G, Zakut H. The corpus caUosum: normal fetal development as shown by transvaginal sonography. AIR Am J Roentgenol 1993;161:1041-1043
10. Achiron R, Achiron A. Development of the human fetal corpus callosum: a high-resolution, cross-sectional sonographic study. Ultrasound Obstet Gynecol 2001;18:343-347
11. Cooke RW, Ahernathy LJ. Cranial magnetic resonance imaging and school performance in very low birth weight infants in adolescence. Arch Dis Child Fetal Neonatal Ed 1999;81:F116-F121
12. Santhouse AM, Ffytche DH, Howard RJ, et al. The functional significance of perinatal corpus callosum damage: an fMRI study in young adults. Brain 2002;125:1782-1792
13. Volpe JJ. Neurobiology of periventricnlar leukomalacia in the premature infant. Pediatr Res 2001;50:553-562
14. Johnston MV, Trescher WH, Jshidia Nakajima W. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr Res 2001;49:735-741
15. Bayley N. Bayley scales of infant development. 2nd ed. San Antonio, TX: Psychological Corporation;1993
16. Anderson NG, Warfield SK, Wells S, et al. A limited range of measures of 2-D ultrasound correlate with 3-D MRI cerebral volumes in the premature infant at term. Ultrasound Med Biol 2004;30:11-18
17. Bland JM, Allman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310
18. Nosarti C, Rushe TM, Woodruff PW, et al. Corpus callosum size and very preterm birth: relationship te neuropsychological outcome. Brain 2004;127:2080-2089
19. Dobbing J. The later development of the brain and its vulnerability. In: Davis JA, Dobbing J, eds. Scientific foundations of paediatrics. 2nd ed. London: Heinemann Medical;1981;744-759
20. Pham D, Xu C, Prince J. Current methods in medical imaging segmentation. Annu Rev Biomed Eng 2000;2:315-337
21. Leviton A, Dammann O, Allred EN, et al. Antenatal corticosteroids and cranial ultrasonographic abnormalities. Am J Obstet Gynecol 1999;181:1007-1017
22. Agarwal R, Chiswick ML, Rimmer S, et al. Antenatal steroids are associated with a reduction in the incidence of cerebral white matter lesions in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2002;86:F96-F101
23. Mercuri E, Longmans M, Henderson S, et al. Evaluation of the corpus callosum in clumsy children born prematurely: a functional and morphological study. Neuropediatrics 1996;27:317-322
24. Davatzikos C, Batzi A, Lawrie J, et al. Correlation of corpus callosum morphometry with cognitive and motor function in periventricular leukomalacia. Neuropediatrics 2003;34:247-252
25. Als H, Duffy FH, McAnulty GB, et al. Early experience alters brain function and strutiure. Pediatrics 2004;113:846-857
26. Tooley JR, Eagle RC, Satas S, Thoresen M. Significant head cooling can be achieved while maintaining normothermia in the newborn piglet. Arch Dis Child Fetal Neonatal Ed 2005;90:F262-F266
27. Strunk T, Hartel C, Schultz C. Does erythropoietin protect the preterm brain? Arch Dis Child Fetal Neonatal Ed 2004;89:F364-F366
28. Follett PL, Deng W, Dai W, et al. Glutamate receptor-mediated oligodcndrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 2004;24:4412-4420
29. Gressens P, Besse L, Robberecht P, et al. Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivatives. J Pharmacol Exp Ther 1999;288:1207-1213